Plasmapp Co., Ltd. (KOSDAQ:405000)
South Korea · Delayed Price · Currency is KRW 3,500.00
-30.00 (-0.85%)
At close: Sep 4, 2026
Plasmapp Revenue
Plasmapp had revenue of 2.82B KRW in the quarter ending March 31, 2026, with 170.81% growth. This brings the company's revenue in the last twelve months to 10.26B, up 44.45% year-over-year. In the year 2025, Plasmapp had annual revenue of 8.48B, down -16.34%.
Revenue (ttm)
10.26B
Revenue Growth
+44.45%
P/S Ratio
1.12
Revenue / Employee
n/a
Employees
n/a
Market Cap
13.43B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.48B | -1.66B | -16.34% |
| Dec 31, 2024 | 10.14B | -2.78B | -21.51% |
| Dec 31, 2023 | 12.92B | -388.39M | -2.92% |
| Dec 31, 2022 | 13.31B | 6.96B | 109.59% |
| Dec 31, 2021 | 6.35B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| KM Corporation | 144.10B |
| Sewoon Medical | 66.53B |
| CG MedTech | 51.20B |
| OSTEONIC | 50.97B |
| DuChemBIO | 41.51B |
| Wonbiogen | 37.80B |
| SCL Science | 30.50B |
| MEDYSSEY Co.,Ltd | 10.60B |